Tejara Capital LTD has filed its 13F form on August 13, 2024 for Q2 2024 where it was disclosed a total value porftolio of $275 Billion distributed in 68 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Roivant Sciences Ltd. with a value of $23.1B, Heron Therapeutics, Inc. with a value of $14.7B, Arcutis Biotherapeutics, Inc. with a value of $12.5B, Liberty Global LTD with a value of $11.2B, and Transocean Ltd. with a value of $10.4B.

Examining the 13F form we can see an increase of $2.93B in the current position value, from $272B to 275B.

Tejara Capital LTD is based out at London, X0

Below you can find more details about Tejara Capital LTD portfolio as well as his latest detailed transactions.

Portfolio value $275 Billion
Healthcare: $109 Billion
Energy: $77 Billion
Technology: $12.1 Billion
Industrials: $9.84 Billion
ETFs: $8.24 Billion
Financial Services: $8.19 Billion
Real Estate: $5.47 Billion
Communication Services: $4.57 Billion
Other: $7.01 Billion

Stock Holdings Table Market Cap. of $300 Millions to $2 Billions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 68
  • Current Value $275 Billion
  • Prior Value $272 Billion
  • Filing
  • Period Q2 2024
  • Filing Date August 13, 2024
  • Form Type 13F-HR
  • Activity in Q2 2024
  • New Purchases 17 stocks
  • Additional Purchases 31 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 12 stocks
Track This Portfolio

Track Tejara Capital LTD Portfolio

Follow Tejara Capital LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tejara Capital LTD, based on Form 13F filings with the SEC.

News

Stay updated on Tejara Capital LTD with notifications on news.